key: cord-0979870-8jc7a98z
authors: Nappi, Francesco
title: Incertitude pathophysiology and management during the first phase of Covid 19 pandemic
date: 2021-03-09
journal: Ann Thorac Surg
DOI: 10.1016/j.athoracsur.2021.02.066
sha: dce29839e4892238572abb87403a288b28d980f1
doc_id: 979870
cord_uid: 8jc7a98z

nan

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

To the Editor:

The case report described by Fukuhara and colleagues renders some considerations 1 .

First, the variability of host immune response plays a crucial role in COVID-19

severity.During the COVID-19 illness, CD3+, CD4+, and CD8+ lymphocyte counts are reduced based on disease stage 2 while the cytokine storm heralds adverse outcomes, which occurs in patients with severe disease due to interleukins such as TNF-α, IL-6, IL-8, and IL- Finally, although we are better equipped to deal with Sars-Cov-2, some aspects linked to diagnostic management remain uncertain. Viral and serologic testing for acute SARS-CoV-2

infection is now recommended for surgical decision-making. Nevertheless, there remains a concern in patients with mild Sars-Cov-2 infection or asymptomatic patients who remain undetected by current screening procedures requiring emergency interventions. 

Acute Type A Aortic Dissection During the COVID-19 Outbreak

Viral and host factors related to the clinical outcome of COVID-19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet

Inflammatory Response and Endothelial Dysfunction Following Cardiopulmonary Bypass : Pathophysiology and Pharmacological Targets